Award

#2023a1515010124

Funder: Natural Science Foundation of Guangdong Province

Funded outputs count: 4

Funder award ID: #2023A1515010124

OpenAlex ID: G2590956841

Ferroptosis vulnerability of enzalutamide resistant prostate cancer conferred by ACSL4 overexpression and GPX4 antagonism

2026 · Yi Zhou, Jiapeng He, et al. · Cell Death and Disease · 1

UHRF1 regulates AR ubiquitination to promote the loss of AR signaling and enzalutamide resistance in progression of prostate cancer

2026 · Yifan Zhang, Zhaojun Yu, et al. · Cell Death and Disease

AR to GR switch modulates differential TDO2-Kyn-AhR signalling to promote the survival and recurrence of treatment-induced dormant cells in prostate cancer

2025 · Sangsang Li, Yifan Zhang, et al. · Cell Discovery · 10

Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer

2024 · Haozhe Zhang, Yi Zhou, et al. · Clinical and Translational Medicine · 19